Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 72 for als

Edit search filters
  1. A Study To Assess FLX-787 In Subjects With Motor Neuron Disease Experiencing Muscle Cramps

    Scottsdale/Phoenix, AZ

  2. Expanded Access Program With Tirasemtiv For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)

    Jacksonville, FL

  3. Personalized Antisense Oligonucleotide Therapy For A Single Patient With CHCHD10 ALS (nL18576)

    Rochester, MN

  4. Intrathecally Administered Gene Therapy APB-102 In Rapidly Progressive ALS Patients With SOD1 Mutations

    Jacksonville, FL, Rochester, MN

  5. A Trial To Evaluate The Efficacy And Safety Of Reldesemtiv In Patients With Amyotrophic Lateral Sclerosis (ALS)

    Jacksonville, FL

  6. A Study To Assess The Safety, Tolerability, Pharmacokinetics, And Effect On Disease Progression Of BIIB078 In Amyotrophic Lateral Sclerosis (ALS) Patients

    Jacksonville, FL

  7. An Efficacy, Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of BIIB067 In Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C))

    Jacksonville, FL, Rochester, MN

  8. Markers of Inflammation in Patients with Motor Neuron Disease (ALS and ALS Variants)

    Scottsdale/Phoenix, AZ

  9. Target ALS Biomarker Study

    Jacksonville, FL

  10. A Study Of Deep Phenotyping In Patients With ALS

    Rochester, MN

.

Mayo Clinic Footer